. Role of the human V 1 vasopressin receptor COOH terminus in internalization and mitogenic signal transduction. Am J Physiol Endocrinol Metab 281: E81-E92, 2001.-We studied the role played by the intracellular COOH-terminal region of the human arginine vasopressin (AVP) V 1 -vascular receptor (V 1 R) in ligand binding, trafficking, and mitogenic signal transduction in Chinese hamster ovary cells stably transfected with the human AVP receptor cDNA clones that we had isolated previously. Truncations, mutations, or chimeric alterations of the V 1 R COOH terminus did not alter ligand binding, but agonist-induced V 1 R internalization and recycling were reduced in the absence of the proximal region of the V 1 R COOH terminus. Coupling to phospholipase C was altered as a function of the COOH-terminal length. Deletion of the proximal portion of the V 1 R COOH terminus or its replacement by the V 2 -renal receptor COOH terminus prevented AVP stimulation of DNA synthesis and progression through the cell cycle. Mutation of a kinase consensus motif in the proximal region of the V 1 R COOH terminus also abolished the mitogenic response. Thus the V 1 R cytoplasmic COOH terminus is not involved in ligand specificity but is instrumental in receptor trafficking and facilitates the interaction between the intracellular loops of the receptor, G protein, and phospholipase C. It is absolutely required for transmission of the mitogenic action of AVP, probably via a specific kinase phosphorylation site. cellular proliferation; G protein-coupled receptors THE ANTIDIURETIC HORMONE 8-ARGININE VASOPRESSIN (AVP) belongs to the family of vasoactive and mitogenic peptides involved in physiological and pathological cell growth, differentiation, and proliferation (40). AVP exerts its actions through binding to specific V 1 -vascular (V 1 R), V 2 -renal (V 2 R), and V 3 -pituitary membrane receptor (V 3 R) subtypes that are coupled to distinct second messengers (34).
undergoing identical splicing (36) . AVP binding to V 1 Rs leads to the activation of phospholipases C, D, and A 2 , the production of inositol 1,4,5-trisphosphate and diacylglycerol, the activation of calcium/calmodulin kinase, phosphatidylinositol 3-kinase (PI 3-kinase), protein kinase C (PKC) and p42/p44 mitogen-activated protein (MAP) kinases, the mobilization of intracellular calcium, the influx of extracellular calcium via receptor-operated Ca 2ϩ channels, and the activation of the Na ϩ -H ϩ exchanger (3, 30, 33) . No stimulation of cAMP accumulation is noted after stimulation of V 1 Rs (32) . The nuclear signals triggered by activation of V 1 Rs are the induction of immediate early-response gene expression and protein synthesis, leading to cellular hypertrophy and increased cell protein content (7) . Indeed, activation of V 1 Rs leads to a mitogenic response in vascular smooth muscle cells, 3T3 cells, renal mesangial cells, hepatocytes, and adrenal glomerulosa cells. This response is specifically blocked by V 1 R antagonists of peptide and nonpeptide nature (29) .
Agonist activation of G protein-coupled receptors (GPCRs) triggers a cascade of events, including G protein coupling, phosphorylation of intracellular domains, internalization of the occupied receptor, and activation of intracellular messengers. Indeed, AVP activation of V 1 R elicits a rapid internalization and phosphorylation of the receptor (11) . The family of AVP receptors is interesting in that its various members are coupled to different G proteins and exert opposite effects on cell growth and proliferation: V 1 R is coupled to G q and produces a mitogenic response, whereas V 2 R is coupled to G s and produces an antimitogenic response (32) . The structural elements of human V 1 R involved in the mitogenic properties of this receptor remain to be identified. Phosphorylation of intracytoplasmic residues of GPCRs plays an obligatory role in signal transmission (25) . Examination of the amino acid composition of human V 1 R and V 2 R reveals the presence of several serine and threonine potential phosphorylation sites at the level of the intracytoplasmic domains of both receptors (Fig. 1) . In contrast, the V 1 R COOH terminus contains one proximal and three distal PKC consensus motifs ([S/T] X [R/K]), whereas human V 2 R has no PKC motif in its COOH-terminal region. To examine the role played by the COOH terminus of the V 1 R in binding characteristics, internalization, recycling, and coupling to the mitogenic signal, we stably transfected Chinese hamster ovary (CHO) cells with a series of human V 1 Rs containing truncated or mutated portions of the COOH terminus. Also, chimeric constructs interchanging the human V 1 R and V 2 R COOH termini were designed. We observed that the human V 1 R COOH terminus is not involved in ligand binding affinity and specificity but modulates agonist-induced receptor internalization and recycling as well as transmission of the mitogenic signal. The V 1 R COOH terminus also alters the efficiency of coupling to phospholipase C. The first kinase motif present in the V 1 R COOH terminus plays a key role in the transmission of the mitogenic signal. Receptor constructs. The human V 1 R cDNA clone that we had isolated previously (31) was modified by PCR with the use of reverse primers hybridizing with the appropriate region of the COOH terminus and introducing an EcoRI restriction site downstream of the new stop codon to produce COOH-terminal regions of various lengths containing increasing numbers of kinase motifs (Fig. 2) . The primers were synthesized with an Applied Biosystems oligonucleotide synthesizer and purified over OPC cartridges according to the manufacturer's recommendations (Applied Biosystems, Foster City, CA). The PCR reactions (final volume 100 l) contained 20 pmol of each primer, 2.5 units of Taq polymerase, 1 g of purified full-length wild-type V 1 R cDNA, 50 M of each dNTPs in buffer of 10 mM Tris ⅐ HCl, 50 mM KCl, 1.5 mM MgCl 2 , 0.1% gelatin, pH 7.4. After initial denaturation at 95°C for 5 min, 35 cycles were run (at 95°C for 45 s, 56°C for 45 s, and 72°C for 1.5 min) with a final extension at 72°C for 7 min. The PCR products were purified (Wizard PCR DNA purification kit from Promega), digested with EcoRI, purified with the GeneClean II kit (Bio 101, Vista, CA), and ligated to the pCI-neo mammalian expression vector.
MATERIAL AND METHODS

Reagents
Also, a chimeric V 1 R/V 2 R construct made of the 5Ј part of the human V 1 R cDNA (Met 1 -Glu 361 ) and the COOH terminus of the human V 2 R cDNA (Ser 338 -Ser 371 ) was produced by digesting both clones with HindIII and ligating back in frame the 5Ј V 1 R fragment with the 3Ј V 2 R fragment before insertion in the pCI-neo vector. The V 2 R cDNA was produced by PCR as described before (32) . A reverse strategy was implemented to produce a V 2 R/V 1 R chimera (Met 1 -Arg 337 of V 2 R ligated to Ser 362 -Thr 418 of the V 1 R) after digestion with HindIII.
The V 1 RS382G-R384G mutant, whose first kinase consensus sequence within the COOH terminus of the human V 1 R was inactivated, was produced by using the QuickChange site-directed mutagenesis kit (Stratagene) according to the manufacturer's recommendations.
The amino acid COOH-terminal sequences of the truncated and mutated V 1 Rs, as well as the chimeric V 1 R/V 2 R and V 2 R/V 1 R clones, are presented in Fig. 2 . The correct sequences of all of the constructs described were verified by double-strand sequencing (Taq Dye Deoxy Terminator cycle sequencing kit and a model 373A sequencer from Applied Biosystems) before CHO-K1 cell transfection.
Selection and stable expression in CHO cells. Stable transfection of CHO-K1 cells with the mutated V 1 R cDNAs was performed using the CaPO 4 precipitation method (31) . Pure clones were selected for their resistance to the antibiotic geneticin (400 g/ml) and purified by the limiting dilution technique. Clones expressing the greatest number of mutated receptors in binding experiments were further explored by radioligand saturation and competition binding experiments as well as measurement of IP production, thymidine uptake, flow cytometry, and cell proliferation, as described next.
Radioligand binding assays. Control and transfected CHO-K1 cells were grown to confluence in 24-well dishes and washed twice with PBS ϩ 10 mM MgCl 2 ϩ 0.2% BSA, pH 7. calculated by the equation of Cheng and Prusoff:
Also H]AVP (5 nM) Ϯ 1 M unlabeled AVP for increasing times Յ60 min (n ϭ 8 for each time point). Each well was washed three times with 0.5 ml of ice-cold PBS. Every other well was incubated with 0.5 M NaCl ϩ 0.2 M acetic acid, pH 2.5, for 10 min on ice to displace surface-bound radioactivity and then was washed three times with 0.5 ml of ice-cold PBS. Radioactivity was counted as described (in Radioligand binding assays) to measure total specific binding and internalized specific binding. The percentage of internalized receptors was plotted against time and analyzed as one-phase exponential association to determine half-life of internalization (t 1/2 in min) and maximum internalization percentage (I max in %).
Receptor recycling. Subconfluent monolayer cultures of CHO-K1 cells transfected with the wild-type or mutated V 1 Rs were grown in 24-well plates. The cells were washed twice and incubated at 37°C in 250 l of PBS ϩ 10 mM MgCl 2 ϩ 0.2% BSA, pH 7.4, with unlabeled AVP (0.1 M) for 20 min (n ϭ 12 for each time point). Each well was washed three times with 1 ml of ice-cold PBS containing 50 mM EDTA to displace AVP bound to the membrane receptors and then washed again three times with 1 ml of ice-cold PBS. The cells were again incubated at 37°C for 0-60 min in 250 l of PBS ϩ 10 mM MgCl 2 ϩ 0.2% BSA, pH 7.4, to allow recycling of the receptors to the cell surface. Thereafter, medium was discarded and replaced by 250 l of ice-cold PBS ϩ 10 mM MgCl 2 ϩ 0.2% BSA, pH 7.4, containing [ 3 H]AVP (5 nM) Ϯ 1 M unlabeled AVP for 2-h incubation on ice. The cells were washed three times with 0.5 ml of ice-cold PBS. Radioactivity was counted as described (in Radioligand binding assays) to measure cell-bound [ 3 H]AVP. The percentage of receptors recycling to the cell surface was plotted against time as a percentage of the total number of surface receptors available before any agonist binding. The half-life of recycling (t 1/2 in min) was calculated from the slope of the relationship.
IP production. Subconfluent monolayer cultures of CHO-K1 cells transfected with the wild-type or mutated V 1 Rs were grown for 48 h in 12-well dishes, washed with inositol-free DMEM, and labeled with myo- [2] [3] H]inositol (2-3 Ci/ml) in inositol-free DMEM for 20-24 h (8). Thereafter, the cells were preincubated for 1 h in DMEM, followed by 15-min preincubation in Hanks' balanced salt solution containing 10 mM glucose, 1.2 mM CaCl 2 , and 10 mM LiCl. Increasing concentrations of AVP were added, and the cells were incubated for 30 min at 37°C. The reaction was stopped by the addition of 0.5 ml of ice-cold methanol-HCl (100:1). The cells were scraped and transferred to glass tubes containing 1 ml of chloroform and 25 g of phytic acid hydrolysate to obtain a final ratio of chloroform-methanol-H 2 O of 10:5:4. After phase separation, the upper phases were removed and loaded onto AG1-X8 Dowex columns (chloride form, 200-400 mesh). Inositol monophosphates, inositol bisphosphates, and inositol trisphosphate were eluted with 30 mM, 90 mM, and 0.5 M HCl, respectively, and quantitated by scintillation spectroscopy. The lower phases containing labeled phosphoinositides were washed with a theoric upperphase solution containing 1 mM inositol and counted. The amount of IPs released was expressed as disintegrations per minute per well or as a fraction of total labeled phosphoinositides. Typical incorporation into phosphoinositides amounted to ϳ3.5-5 ϫ 10 4 [ 3 H]dpm/well. The efficacy (EC 50 ) of AVP stimulation of IP production was calculated by a nonlinear least-squares analysis program.
[ 3 H]thymidime uptake. Subconfluent monolayer cultures of CHO-K1 cells transfected with the wild-type or mutated V 1 Rs were grown in F12 medium ϩ 10% FBS at 37°C for 48 h in 24-well plates to measure thymidine uptake in the presence of AVP, as described before (34) . Cells were washed in 500 l of F12 medium and grown for 72 h in 500 l of F12 medium ϩ 25 mM HEPES ϩ 0.1% BSA. Increasing concentrations of AVP (10
Ϫ6 M final concentrations) were added to the wells, and 18 h later, 10 Ci of [ 3 H]thymidine were added for 45 min. The cells were transferred on ice, washed twice with 0.5 ml of ice-cold PBS, fixed with 1 ml of ice-cold 10% trichloroacetic acid (TCA) for 30 min at 4°C, washed twice with 1 ml of ice-cold 5% TCA solution, and solubilized with 250 l of 0.1 N NaOH-0.1% SDS. Aliquots were collected for radioactivity determination.
Flow cytometric analysis. Subconfluent cultures of CHO-K1 cells transfected with the wild-type or mutated V 1 Rs were grown in F12 medium ϩ 15 mM HEPES and 10% FBS at 37°C for 48 h in 100-mm dishes to assess cell cycle progression in the presence of AVP. Cells were serum starved for 5 days in F12 medium ϩ 15 mM HEPES and 0.1% BSA. Thereafter, AVP (10 Ϫ8 M final concentration) was added alone or in the presence of various inhibitors, and 24 h later, the cells were harvested. Flow cytometric analysis (FACS) was performed after the nuclei were labeled with propidium iodide (PI). PI was excited with an air-cooled argon-ion laser operating at 15 mW at 488 nm (EPICS XL-MCL, Coulter, Miami, FL). Linear and peak PI fluorescence was collected with a 620-nm band pass optical filter. Linear and peak fluorescence was plotted as bivariate parameters to form a doublet discriminator that was used to estimate the single cell, cell aggregate, and apoptotic cells in the sample. System II software was used to acquire the data, and ModFIT 5.2 (Verity Software House, Topsham, ME) was used to model cell cycle phases.
Data analysis. Nucleotide and amino acid sequences were analyzed with the computer package MacVector (Oxford Molecular, Oxford, UK). Nonlinear least-squares analysis was performed with the Kaleidagraph software package from Synergy Software (Reading, PA). Data are expressed as means Ϯ SE.
fected CHO cells; moreover, no specific binding was observed in cells transfected with the pCI-neo vector alone (data not shown).
Saturation binding experiments performed with [ 3 H]AVP in intact CHO cells transfected with the mutated V 1 R cDNAs revealed a single class of high-affinity binding sites in all mutated clones (Table 1) . Hence, the various truncations, mutations, and/or chimeric alterations of the V 1 R COOH terminus did not hamper the receptor insertion inside the cell membrane. The affinity of the mutated V 1 R clones for the native ligand AVP (expressed as K d value) was similar to that of the wild-type receptor, except for the V 2 R/V 1 R chimera, whose K d was slightly, but significantly, increased to 1.61 nM. Interestingly, this V 2 R/V 1 R chimera displayed the lowest level of expression among the various constructs developed for this study.
Competition binding experiments confirmed that all of the truncated and mutated V 1 Rs still displayed a typical V 1 R subtype binding profile (data not shown). More importantly, the affinity of the V 1 R/V 2 R chimeric construct (whose COOH terminus was exclusively made of the human V 2 R subtype sequence) for AVP and the nonpeptide V 1 R antagonist SR-49059 remained high (K i ϭ 0.85 Ϯ 0.09 and 0.76 Ϯ 0.14 nM, respectively), whereas the affinity for the nonpeptide V 2 R antagonist SR-121463A was low (K i ϭ 2,314 Ϯ 157 nM; Fig. 3A) . Conversely, the affinity of the V 2 R/V 1 R chimeric construct (whose COOH terminus was exclusively made of the human V 1 R subtype sequence) for AVP and the nonpeptide V 2 R antagonist SR-121463A was high (K i ϭ 1.61 Ϯ 0.06 and 1.08 Ϯ 0.08 nM, respectively), whereas the affinity for the nonpeptide V 1 R antagonist SR-49059 was low (K i ϭ 228 Ϯ 9 nM; Fig. 3B ). These observations suggest that the COOHterminal portion of the human V 1 R is not required for proper folding and cell surface expression of the receptor. Furthermore, it is not involved in the determination of ligand receptor subtype selectivity.
Internalization and recycling of the agonist-occupied mutated receptors. Platelet and hepatic V 1 AVP receptors internalize and recycle once they are occupied by AVP (6, 30) . The molecular determinants underlying the internalization, sequestration, and recycling of the AVP/oxytocin (OT) receptor family remain largely unexplored, but the involvement of the third intracytoplasmic loop and the COOH terminus has been suggested for other G protein-coupled receptor (GPCR) families (9, 20) . We explored the possible interference of truncations of the V 1 R COOH terminus with the internalization and recycling of the AVP receptors in the stably transfected CHO cells expressing the mutated clones. As shown in Fig. 4 , the wild-type V 1 R was quickly internalized at 37°C with an internalization half-life of 5 min and a maximal amount of internal- ization of 89%. For the V 1 R359X mutant, the extent of internalization was reduced to 54%, and the internalization half-life was slightly slower (6 min). The internalization pattern for the V 1 R399X, V 1 R406X, V 1 R409X, and V 1 RS382G-R384G mutants was similar to that of the wild-type V 1 R (internalization half-life between 4 and 5 min, maximal level of internalization between 82 and 94%), thus suggesting that only the NH 2 -terminal portion of the V 1 R COOH terminus plays a significant role in its internalization. Like other investigators (12), we observed that the internalization rate of the V 2 R was slower than that of the V 1 R: the internalization half-life of the wild-type V 2 R in CHO cells was 13 min, and the maximal level of internalization was 91%. The internalization rate of the V 1 R/V 2 R chimera (internalization half-life of 4 min) was similar to that of the wild-type V 1 R, whereas the internalization of the V 2 R/V 1 R chimeric receptor was slower than that of the wild-type receptors (internalization half-life of 19 min).
Agonist-promoted internalization of AVP receptors is followed by rapid recycling of the receptors to the cell surface after removal of the hormone from the medium (13). Thus we looked at the role played by the V 1 R COOH terminus in the recycling process of the receptor. As shown in Fig. 5 , only 10% of the wild-type V 1 Rs remained at the cell surface after a 20-min exposure to 100 nM AVP at 37°C. After removal of the agonist, the wild-type V 1 Rs recycled quickly to the cell surface at 37°C (recycling half-life of 19 min). At variance, 50% of the V 1 R359X mutant still remained at the cell surface after a 20-min exposure to 100 nM AVP at 37°C, and recycling of the V 1 R359X mutant to the cell surface occurred at a slower pace (recycling half-life of 35 min). Recycling of the V 1 R399X, V 1 R406X, V 1 R409X, and V 1 RS382G-R384G mutants was similar to that of the wild-type V 1 R (data not shown).
AVP-induced IP production in CHO cells expressing mutated receptors. V 1 Rs are coupled to phospholipase C with a subsequent increased production of IPs. The signal transduction of the mutated human V 1 Rs was explored by measuring AVP-induced IP production in CHO cells stably transfected with the wild-type or mutated V 1 Rs (Table 2 ). In CHO-K1 cells transfected with the wild-type V 1 R, AVP produced a dose-dependent increase in the formation of IP that was blocked by the nonpeptide V 1 R antagonist SR-49059 but not by the nonpeptide V 2 R antagonist SR-121643A (data not shown). AVP could still stimulate IP production in cells expressing the truncated V 1 Rs. The maximum response was similar to that noted for the wild-type receptor (57-to 60-fold increase), but there was a shift in the dose-response curve to the right that was related to the length of the COOH terminus of the various mutants and, presumably, the number of available PKC sites. AVP stimulation of IP production in the V 1 RS382G-R384G mutant receptor was normal. The V 1 R/V 2 R chimera was also able to stimulate IP produc- 3 H]thymidine uptake was measured in CHO cells transfected with the wild-type or the mutated form of the human V 1 R. AVP stimulation of DNA synthesis required the involvement of the receptor COOH-terminal proximal portion as shown in Fig. 6 . There was a progressive restoration of DNA synthesis with the lengthening of the COOH terminus. The proximal PKC consensus site of the V 1 R COOH terminus seemed to play a major role in the mitogenic signal, because AVP effect on thymidine uptake was lost in the V 1 RS382G-R384G mutant receptor. Introduction of the V 2 R COOH terminus into the V 1 R sequence led to a dramatic reduction of AVP stimulation of DNA synthesis as found in the V 1 R/V 2 R chimeric clone. Of interest is the fact that introduction of the V 1 R COOH terminus into the V 2 R sequence was not sufficient to stimulate DNA synthesis by the V 2 R/V 1 R chimera. These data suggest that, as for IP production, the COOH terminus of the V 1 R participates in the stimulation of DNA synthesis but cannot elicit such a response by itself.
AVP-induced progression through the cell cycle in cells expressing mutated AVP receptors.
Thibonnier et al. (33) recently showed that, in CHO cells transfected with the wild-type V 1 R, AVP induced a progression through both the S and G 2 -M phases of the cell cycle. We explored here the effect of AVP on cell cycle progression in the V 1 R mutated clones. Compared with the wild-type V 1 R, AVP no longer produced progression through the cell cycle in the V 1 R359X truncated mutant (Fig. 7) . AVP produced a normal progression through the cell cycle in the mutants displaying the proximal portion of the V 1 R COOH terminus (V 1 R399X, V 1 R406X, and V 1 R409X clones; data not shown). AVP stimulation of the V 1 RS382G-R384G mutant receptor produced a progression from the G 0 -G 1 phase to the S phase but no further progression to the G 2 -M phase (Fig. 7) . Study of the cell cycle progression in the chimeric V 1 R/V 2 R and V 2 R/V 1 R clones revealed patterns similar to those of the corresponding wildtype receptors, i.e., cell cycle progression for the V 1 R/ V 2 R clone but no cell cycle progression for the V 2 R/V 1 R chimera (data not shown). These data suggest that, as for IP production and DNA synthesis, the COOH terminus of the V 1 R participates in the effect of AVP on cell cycle progression but cannot elicit such a response by itself.
DISCUSSION
The superfamily of GPCRs is structurally defined by an extracellular NH 2 terminus, seven transmembrane domains, and an intracellular COOH terminus. Interaction with G proteins and intracellular messengers takes place at the level of the intracytoplasmic regions of the receptors. The length of the COOH terminus of GPCRs is highly variable, from being absent in the gonadotropin-releasing hormone receptor to measuring up to 162 amino acids (1) . Comparison of the family of AVP/OT receptors reveals variable COOH-terminal lengths (arbitrarily counted after the conserved cysteine-cysteine motif located after the seventh transmembrane domain): 51 amino acids for the V 1 R, 29 for the V 2 R, 68 for the V 3 R, and 42 for the OTR. The V 1 R and V 2 R COOH termini differ not only in their length but also in their amino acid composition. The V 1 R COOH terminus contains 16 serine and threonine residues and four PKC consensus sites ([S/T] X [R/K]), whereas the V 2 R COOH terminus contains 12 serine and threonine residues but no PKC consensus site. Because of these structural differences between the V 1 R and V 2 R COOH termini and the opposite effects of these two structurally related receptors on cell proliferation, we studied the role of the receptor COOH termini in binding characteristics and signal transduction patterns in mutated, truncated, and chimeric forms of human V 1 R and V 2 R.
Truncations, mutations, and chimeric alterations of the human V 1 R COOH terminus do not hinder the expression, processing, or normal insertion of the receptor inside the cell membrane, as shown by our ligand-binding experiments performed in intact cells. In addition, structural alterations of the human V 1 R COOH terminus did not modify the ligand-binding characteristics of the receptor. Affinity for the native ligand AVP remained excellent; moreover, the insertion of the V 2 R COOH terminus into the V 1 R sequence did not modify the V 1 R subtype ligand selectivity. Likewise, insertion of the V 1 R COOH terminus into the V 2 R sequence did not modify the V 2 R subtype ligand selectivity.
However, the V 2 R/V 1 R chimera's affinity for [ 3 H]AVP was slightly but significantly reduced, and the level of expression of this particular clone was not as high as that of the other constructs. Site-directed mutagenesis experiments conducted by several investigators with the V 1 R, V 2 R, and OTR from different species indicate that the ligand-binding pocket and the molecular determinants of AVP/OT receptor subtype ligand specificity are located in the extracellular loops and the upper part of the transmembrane domains of the receptors (4, 14, 21, 26, 39) . In agreement with our findings, Liu and Wess (16) observed that chimeric constructs exchanging the rat V 1 R and the human V 2 R COOH termini did not alter high-affinity ligand binding. We observed that the deletion of the V 1 R COOH terminus did not prevent the receptor from being properly folded and expressed at the cell surface. These observations are different from those reported for the V 2 R. Truncation of the last 14 and 27 amino acids of the human V 2 R (V 2 R345X and V 2 R358X mutants) did not alter membrane insertion and binding affinity of the mutant receptors (12) . However, complete deletion of the COOH terminus of the human V 2 R (V 2 R337X mutant) reduced the membrane integration of the V 2 R, which was retained inside the endoplasmic reticulum and no longer coupled to adenylyl cyclase (22) . Increasing the number of COOH-terminal residues (truncations after codons 348, 354, and 356) restored G protein coupling but produced a length-dependent reduction of cell surface expression. These data suggest that residues in the NH 2 -terminal part of the human V 2 R COOH terminus are necessary for correct folding and that COOH-terminal residues are important for efficient cell surface expression. Moreover, a chimeric V 2 R with a ␤ 2 -adrenergic receptor COOH terminus also did not bind AVP and was retained inside the cells. Thus it appears that the COOH termini of the V 1 R and the V 2 R play different roles in terms of receptor folding, membrane insertion, and, consequently, ligand binding; the V 1 R receptor's COOH terminus is not involved in these processes, whereas specific amino acids in the proximal portion of V 2 R receptor COOH terminus are required.
The amino acid residues of the proximal portion of the V 2 R receptor COOH terminus involved in proper membrane insertion remain to be identified. On the basis of the work done by Sadeghi et al. (28) with the human V 2 R, the two adjacent cysteines that are conserved in the COOH terminus of the AVP/OT receptor family are palmitoylated but are not required for AVP binding, as their replacement did not alter ligandbinding affinity, AVP-stimulation of adenylyl cyclase, receptor internalization, or desensitization. Similarly, mutations of the two adjacent cysteines of the rat V 1 R did not alter ligand-binding affinity or AVP stimulation of intracellular calcium release, desensitization, and internalization (27) .
Cell surface receptors internalize through clathrincoated pits and vesicles, a phenomenon that is usually triggered by agonist ligand occupancy of the receptor ligand-binding pocket. Various segments of the COOHterminal region of several GPCRs are involved in signal transduction, endocytosis, and desensitization. For instance, endocytosis of the angiotensin II type 1 receptor (AT 1a ) involves two distinct regions of the COOH terminus, one that is rich in hydrophobic and aromatic residues (residues 315-329) and another distal to Lys 333 that contains several serine and threonine residues (37) . Maximal endocytosis of the AT 1a receptor requires phosphorylation of this serine/threoninerich segment of the COOH terminus (38) . Our study indicates that the proximal portion of the V 1 R COOH terminus between residues 360 and 399 modulates the extent of receptor internalization, whereas the distal portion of the V 1 R COOH terminus between residues 399 and 418 does not seem to be involved in the process. These findings are unique to the human V 1 R, as a study revealed that deletion of the last 51 amino acids of the rat V 1 R did not affect internalization of the receptor (27) . However, the deletion of 14 additional amino acids in the rat V 1 R sequence did impair internalization of the receptor. Mutation of Cys 371 and Cys 372 of the rat V 1 R sequence (which are also missing in our V 1 R359X mutant) decreased endocytosis by 26%. Substitution of Leu 361 and Leu 362 of the rat V 1 R sequence (two residues that are present in our V 1 R359X mutant in positions 355 and 356) reduced endocytosis by 56% without affecting calcium signaling. Krause et al. (15) recently reported that the conserved glutamate-dileucine motif present in the COOH terminus of the human V 2 R functions as a small, linear vesicular transport signal that is essential for receptor transport from the endoplasmic reticulum to the Golgi apparatus. Three-dimensional modeling predicted that this glutamate-dileucine motif forms a U-like loop within the intracellular COOH terminus. In addition, Leu 339 constitutes a close hydrophobic interaction with Ala 61 and Leu 62 of the first cytoplasmic loop. The determination of the crystal structure of rhodopsin at 2.8-Å resolution confirmed the existence of a fourth intracellular loop that forms a helical structure lying perpendicular to the seventh transmembrane domain (23) . This fourth intracellular loop facilitates the stabilization of rhodopsin by a number of intramolecular interactions. From these studies, one may conclude that the two adjacent cysteines present in the proximal portion of the COOH terminus are involved in the internalization of both the human and rat V 1 Rs, but the upstream dileucine motif is instrumental in the internalization of the rat V 1 R only. Our data also suggest that the same segment of the human V 1 R COOH terminus is involved in receptor recycling. The COOH terminus of the V 2 R is also instrumental in its internalization, but it appears that it is the distal portion that plays a significant role, because a deletion of the last 14 amino acids of the V 2 R impaired internalization to a greater extent than the deletion of the last 27 amino acids (12) . The mechanisms that underlie the internalization of GPCRs are quite complex and in some cases require receptor phosphorylation. For instance, PKC activation of the sst2A somatostatin receptor potentiates internalization of the receptor via clathrin-coated pits (10) . At variance, our data suggest that PKC activation of the V 1 R, which is required for signal transduction, is not involved in receptor internalization, because the mutation of the first kinase consensus motif present in the V 1 R COOH terminus did not alter its internalization pattern. Similarly, the absence of PKC consensus motifs in the V 2 R COOH terminus excludes a role for this kinase in the internalization process of the family of AVP/OT receptors. The molecular determinants of the proximal portion of the V 1 R COOH terminus playing a role in its internalization will have to be determined by further mutational experiments. A recent work done by Preisser et al. (27) , who measured by ELISA the internalization of the rat V 1 R, suggests that removal of the last 51 amino acids did not significantly alter the kinetics or amplitude of internalization, whereas deletion of the last 65 amino acids reduced receptor internalization by 80%.
Our data indicate that the COOH terminus of the human V 1 R is involved in signal transduction. As for the internalization pattern, the proximal portion of the V 1 R seems to be the critical segment involved. The systematic exchange of the V 1 R and V 2 R intracellular domains performed by Liu and Wess (16) revealed that the V 1 R's second intracellular loop was required for activation of the phosphatidylinositol pathway, whereas the V 2 R's third intracellular loop was required for activation of the adenylyl cyclase pathway. In a subsequent article, Erlenbach and Wess (5) reported that other AVP receptor domains besides the intracellular loops were also critical for optimum G proteincoupling efficiency. Substitution of the 21 amino acids of the proximal portion of the V 2 R COOH terminus in the V 1 R sequence resulted in a chimeric receptor that gained the ability to stimulate cAMP production to a significant extent (29% of maximum effect of the wildtype V 2 R). Insertion into the V 1 R sequence of both the third intracellular loop and the proximal portion of the V 2 R COOH terminus led to an agonist-induced production of cAMP similar to that of the wild-type V 2 R. These observations suggest that different segments of the V 2 R cooperate to produce a maximal activation of adenylyl cyclase, presumably through G s coupling. Similarly, our own data with the V 1 R indicate that the proximal portion of the V 1 R COOH terminus contributes to the receptor-coupling selectivity and optimizes the efficiency of IP production. However, this segment must work in concert with other fragments of the receptor (presumably the second intracellular loop) to produce efficient G q/11 coupling and phospholipase C activation, because the V 1 R COOH terminus by itself does not generate such signals and its replacement by the V 2 R COOH terminus does not result in dramatic alterations of IP production. Similarly, introduction of the V 1 R COOH terminus into the V 2 R sequence is not sufficient to elicit G q/11 coupling. Moreover, the proximal portion of the V 1 R is absolutely required to observe a mitogenic signal. This mitogenic signal seems to necessitate the intervention of a kinase, because the inactivation of the first kinase consensus site in the proximal region of the V 1 R COOH terminus led to the loss of the mitogenic response. Indeed, Berrada et al. (2) recently reported that the inactivation of the first kinase consensus motif within the COOH terminus of the human V 1 R led to a dramatic reduction of the receptor phosphorylation. Nevertheless, the proximal region of the V 1 R COOH terminus is not sufficient to elicit such a signal by itself, because the introduction of the V 1 R COOH terminus into the V 2 R sequence could not produce a mitogenic signal. From these findings, one may conclude that the COOH terminus of the V 1 R is an active component of the scaffolding role of the receptor that coordinates protein interactions with the receptor (17) . Agonist-induced activation of GPCRs leads to the successive phosphorylation by G proteincoupled receptor kinase, binding of ␤-arrestins, and recruitment of several kinases including c-Src, extracellular factor-regulated kinase (ERK)1, ERK2, and c-Jun kinase 3 (18, 19) . The proximal portion of the V 1 R is presumably involved in the formation of such scaffolding. In its absence, coupling to phospholipase C is still present, albeit with a reduced efficiency, but the further addition of downstream kinases of the scaffolding is hampered, with subsequent loss of the mitogenic signal.
Hormones modulate cellular phenotype through interaction with the cell cycle machinery by regulating cell cycle control proteins through various pathways. Several members of the GPCR family that alter cellular differentiation, proliferation, and apoptosis do so by modifying the transition between different cell cycle states (24) . For instance, angiotensin II stimulates G 1 phase progression via induction of cyclin D 1 (CD 1 ) mRNA and CD 1 K activity, presumably through a ras-ERK-AP1 pathway (41) . We observed that AVP activation of the V 1 R led to a progression through the cell cycle all the way to the M phase, in agreement with previous assessment of cell proliferation (34) . Thibonnier et al. (33) have previously shown that this progression was mediated by the simultaneous and parallel activation of several kinase pathways, mainly calcium/ calmodulin kinase II, PI 3-kinase, and PKC-p42/p44 MAP kinase. Our data with the V 1 RS382G-R384G mutant receptor suggest that AVP stimulation may activate not only the CD 1 complex controlling the restriction point of the G 1 phase but also the cyclin B-cdc2 complex that controls mitogenic entry. This point will be investigated in the near future.
In conclusion, we have shown that the COOH terminus of the human V 1 R plays an important role in the trafficking of the receptor and works in concert with other intracytoplasmic segments of the receptor to elicit a mitogenic signal.
